Compounding Pharmacies Market is projected to Reflect 6% CAGR throughout 2015 - 2021

According to the latest market report published by Persistence Market Research titled ‘Global Market Study on Compounding Pharmacies: Asia Pacific is expected to witness highest growth by 2021’, the global compounding pharmacies market is projected to expand at a CAGR of 6% during the forecast period (2015 - 2021). Compounding pharmacies accounted for market revenue worth US$ 6.5 Bn in 2014 and the revenue is expected to increase to US$ 9.75 Bn by 2021.

Compounding pharmacies produce personalized medicines, which can be altered by dosages, medicinal strengths, forms, and medium of administration, under the guidance of licensed pharmacists and physicians. The market for compounding pharmacies – though shrouded by regulatory restrictions and product quality conformations – presents a lucrative opportunity as compounded drugs offer ease of accessibility, affordability, and administration to potential customers. The report analyzes the global compounding pharmacies market in terms of market value by end use, product, region, and therapeutic area; and provides information regarding regional market dynamics, regulations, PEST analysis, competitive landscape, current trends, market estimations, and forecast.

View and Download TOC of Compounding Pharmacies Market Research Report @ https://www.persistencemarketresearch.com/market-research/compounding-pharmacies-market/toc

Among therapeutic segments, compounding pharmacies find largest application in the pain management industry followed by hormone replacement therapy and others. The hormone replacement therapy segment is expected to gain traction in the near future due to increasing demand for anti-ageing solutions. Increasing demand for high-quality dermatological products is also influencing manufacturers to opt for better quality active pharmaceutical ingredients and maintain a sterile microbial contamination-free manufacturing space. Creams and gels are the most popular products in dermatology, followed by transdermal application products, largely popular in tropical countries.

By end use type, the compounding pharmacies market is segmented into medications for adults, children, and geriatric population along with veterinary drugs. Medications for the adult segment is expected to dominate the overall compounding pharmacies market by the end of the forecast period. The segment is projected to register an above average growth rate over the forecast period. However, veterinary compounded drugs are also gaining traction as these drugs are available in alternate forms and in varying strengths not commercially available.

Request and Download Sample Report @ https://www.persistencemarketresearch.com/samples/5270

Globally, Asia Pacific is expected to dominate the market throughout the forecast period, driven by the promotion of innovative therapies and product formulations by major players in the market. Singapore and Australia are the two major growth promoting countries for compounding pharmacies in Asia Pacific. The compounding pharmacies market in Singapore is expected to increase from a current estimated value of US$ 204.9 Mn in 2015 to US$ 387.2 Mn by 2021, registering a CAGR of 11% over the forecast period. Increase in demand for drugs prone to medicinal drought, personalized dosages, and innovative therapeutic areas is expected to boost overall demand for compounding pharmacies worldwide. Upcoming regulatory harmonization and the need for manufacturing facilities to adhere to good manufacturing practices listed under the U.S. and EU pharmacopeias are set to standardize the compounding pharmacies market. Compounded drug manufacturers in Australia have been mandated to adhere by rules listed under the Australian Therapeutic Goods Administration (TGA). Latin America and Europe are the subsequent lucrative destinations for compounding pharmacies.

Key market players covered in the report include B. Braun Melsungen AG Company, Fagron, PharMEDium Services LLC, Institutional Pharmacy Solutions, Cantrell Drug Company, Triangle Compounding Pharmacies, Lorraine’s Pharmacy, and Fresenius Kabi AG.

Buy Full Compounding Pharmacies Market Report @ https://www.persistencemarketresearch.com/checkout/5270

About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Contact

Persistence Market Research Pvt. Ltd

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com

media@persistencemarketresearch.com

Web: www.persistencemarketresearch.com

This release was published on openPR.